Analyze Diet

Topic:Vaccine

Vaccination in horses involves the administration of biological preparations designed to stimulate the equine immune system to recognize and combat specific pathogens. Vaccines are formulated to prevent or reduce the severity of infectious diseases that can affect equine health and performance. Common vaccines for horses include those for equine influenza, tetanus, equine herpesvirus, and West Nile virus. The administration schedule and type of vaccine can vary based on factors such as geographic location, age, and use of the horse. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, and safety of vaccines in horses, as well as their impact on equine health management.
[New drugs for horses and production animals in 2024].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    April 15, 2025   Volume 53, Issue 2 120-131 doi: 10.1055/a-2559-5769
Kamutzki CJ, Emmerich IU.In 2024, there was no release of a novel pharmaceutical agent for horses and food-producing animals or an extension of existing active ingredients to other animal species on the German veterinary medicinal products market. Formic acid is now available for a new form of treatment, the short-term treatment of honeybees, and clenbuterol is available in a new dosage form, as an oral solution for horses. In the field of immunological veterinary medicinal products, three new vaccines were launched on the German veterinary medicinal products market. For the first time, a vaccine against in cattle, a...
Stochastic modeling of the horse population and vaccination data indicates low annual vaccination coverage for West Nile virus in Canada (2016-2020). Levasseur A, Paré J, Aubry P, Iwasawa S, Leung D, Arsenault J.Vaccination is the most efficient tool for preventing West Nile virus (WNV) disease in horses. The objectives of this retrospective study were to: i) estimate the provincial and national horse population in Canada; ii) estimate the annual vaccination coverage for WNV in each province; and iii) compare estimates of provincial annual vaccination coverage. Horse population data (2006-2023) and the number of vaccine doses sold in Canada (2016-2020) were obtained by province. Based on these data and expert consultations, the annual number of vaccine doses administered, and provincial horse populati...
The Effect of Vaccination Status on Total Lymphocyte Count in Horses Affected by Equine Herpes Virus-1 Myeloencephalopathy.
Animals : an open access journal from MDPI    April 1, 2025   Volume 15, Issue 7 doi: 10.3390/ani15071019
de la Cuesta-Torrado M, Vitale V, Velloso Alvarez A, Neira-Egea P, Diss C, Cuervo-Arango J.Equine herpesvirus 1-induced myeloencephalopathy has a significant impact on the equine industry. Nevertheless, the clinical variables that may affect the severity of the disease are still under investigation. The objective of this research is studying the relationship between the level of lymphopenia and vaccination status with the severity of the disease in horses at an event, considering whether they had been correctly vaccinated or not prior to exposure to EHV-1. Ten horses were admitted to a veterinary teaching hospital following an equine herpesvirus myeloencephalopathy outbreak during a...
Equine Rotavirus A Outbreaks in Ireland (2023-2024): An Epidemiological Investigation and Virus Genotyping.
Viruses    March 31, 2025   Volume 17, Issue 4 511 doi: 10.3390/v17040511
Cullinane A, Garvey M, Dayot L, Lukaseviciute G.Equine rotavirus A (RVA) is a major cause of debilitating diarrhoea in neonatal foals globally. The aim of this study was to characterise RVA viruses currently circulating in Ireland and to identify risk factors associated with disease outbreaks. Of the 377 samples submitted during 2023 and 2024, 48 foals from 36 outbreaks were confirmed to be RVA-positive by real-time PCR. The viruses detected were genotyped by VP7 and VP4 gene sequencing. In 2024, the attending veterinary surgeon was contacted, and epidemiological data were collected. These included the vaccination status of the foal's dam a...
[Correction: Statement on the efficacy and immunological safety of EHV vaccines in horses].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    March 26, 2025   Volume 53, Issue 1 e1 doi: 10.1055/a-2560-3065
No abstract available
Vaccination Status of Horses in Poland Based on an Internet Survey of the Horse Owners.
Animals : an open access journal from MDPI    March 14, 2025   Volume 15, Issue 6 doi: 10.3390/ani15060834
Rykala M, Jasiak M, Niedzwiedz A.Preventing the spread of infectious diseases in horses requires breaking the chain of infection through appropriate prophylaxis. In Poland, where the horse population reached 273,006 in 2023, vaccinations are voluntary and primarily the responsibility of horse owners, with mandatory influenza vaccinations limited to sport horses. This study aimed to evaluate the vaccination status of Polish horses against infectious diseases through a survey of 980 horse owners and an analysis of 123 horse passports from slaughterhouses. Survey participants represented all provinces, predominantly owning warmb...
Emergence of Equine-like G3P[8] Rotavirus Strains Infecting Children in Venezuela.
Viruses    March 13, 2025   Volume 17, Issue 3 410 doi: 10.3390/v17030410
is the leading cause of acute gastroenteritis worldwide in young humans and animals. In 2023-2024, a relatively high rotavirus detection rate (34.5%) was detected in children with diarrhea in Caracas. All rotavirus strains were typed as P[8], using a multiplex RT-PCR assay, while the G-type was not identified. This unusual pattern, not previously observed in Venezuela, prompted the VP7 gene sequencing of nineteen strains, which displayed a high sequence identity (99.3-100%) compatible with the G3 genotype. These strains clustered into a well-supported lineage IX encompassing human reassortant...
Increase in Virus-Specific Mucosal Antibodies in the Upper Respiratory Tract Following Intramuscular Vaccination of Previously Exposed Horses Against Equine Herpesvirus Type-1/4.
Vaccines    March 10, 2025   Volume 13, Issue 3 290 doi: 10.3390/vaccines13030290
Wagner B, Schnabel CL, Rollins A.Equine herpesvirus type-1 (EHV-1) enters through the upper respiratory tract (URT) and causes respiratory disease, abortions, and myeloencephalopathy in equids. Pre-existing immunity at the viral entry site, especially mucosal IgG4/7 antibodies, has recently been shown to correlate with protection from disease and incomplete viral replication at the URT. Here, we tested whether intramuscular (i.m.) vaccination with a commercial inactivated EHV-1/4 vaccine can induce mucosal antibodies (mucAbs) at the URT. Methods: Adult horses with complete EHV-1 vaccination and/or exposure histories were vacc...
Development and Validation of a Differentiating Infected from Vaccinated Animals (DIVA) Enzyme-Linked Immunosorbent Assay (ELISA) Strategy for Distinguishing Between Hendra-Infected and Vaccinated Horses.
Viruses    February 28, 2025   Volume 17, Issue 3 doi: 10.3390/v17030354
McNabb L, McMahon A, Woube EG, Agnihotri K, Colling A, Broder CC, Kucinskaite-Kodze I, Petraityte-Burneikiene R, Bowden TR, Halpin K.Hendra virus (HeV) is a bat-borne zoonotic agent which can cause a severe and highly fatal disease and can be transferred from animals to humans. It has caused over 100 deaths in horses since it was discovered in 1994. Four out of seven infected humans have died. Since the release of the HeV vaccine (Equivac® HeV Hendra Virus Vaccine for Horses, Zoetis Australia Pty Ltd., Rhodes, NSW 2138) in Australia, there has been an urgent requirement for a serological test for differentiating infected from vaccinated animals (DIVA). All first-line diagnostic serological assays at the Australian Centre f...
Equine Influenza: Epidemiology, Pathogenesis, and Strategies for Prevention and Control.
Viruses    February 21, 2025   Volume 17, Issue 3 doi: 10.3390/v17030302
Branda F, Yon DK, Albanese M, Binetti E, Giovanetti M, Ciccozzi A, Ciccozzi M, Scarpa F, Ceccarelli G.Equine influenza (EI) is a highly contagious respiratory disease caused by the equine influenza virus (EIV), posing a significant threat to equine populations worldwide. EIV exhibits considerable antigenic variability due to its segmented genome, complicating long-term disease control efforts. Although infections are rarely fatal, EIV's high transmissibility results in widespread outbreaks, leading to substantial morbidity and considerable economic impacts on veterinary care, quarantine, and equestrian activities. The H3N8 subtype has undergone significant antigenic evolution, resulting in the...
[Statement on the efficacy and immunological safety of EHV vaccines in horses].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    February 18, 2025   Volume 53, Issue 1 39-48 doi: 10.1055/a-2518-1976
In February 2021, a serious EHV-1 outbreak occurred at an international jumping competition in Valencia, with several subsequent outbreaks in various European countries. As a consequence, several equestrian associations introduced compulsory vaccination against EHV-1, and in the immediate aftermath of the outbreak, demand for EHV vaccinations increased sharply. The initial concern has now dissipated. One equestrian association has abolished the compulsory vaccination that had only been introduced a year before, and a general debate began questioning the efficacy and safety of EHV-vaccines. Thi...
[Guidelines for the vaccination of horses – 5th edition].
Tierarztliche Praxis. Ausgabe G, Grosstiere/Nutztiere    February 18, 2025   Volume 53, Issue 1 33-38 doi: 10.1055/a-2517-4204
Vaccination is one of the most important measures for preventing infectious diseases. Vaccinations against tetanus and West-Nile-Virus are essential to protect the individual horse. These infections are not contagious and are not transmitted from animal to animal. By contrast, Equine Influenza and Equine-Herpes-Virus infections are highly contagious, transmissible diseases. In addition to protecting the vaccinated individual, vaccinating as many horses as possible aims at inducing a broad herd immunity, which interrupts infection chains and thus additionally protects the individual. Vaccinatio...
Protective efficacy of a bivalent equine influenza H3N8 virus-like particle vaccine in horses.
Vaccine    February 11, 2025   Volume 50 126861 doi: 10.1016/j.vaccine.2025.126861
O'Kennedy MM, Reedy SE, Abolnik C, Khan A, Smith T, du Preez I, Olajide E, Daly J, Cullinane A, Chambers TM.Equine influenza (EI) is a highly contagious acute respiratory disease of wild and domesticated horses, donkeys, mules, and other Equidae. EI is caused by the Equine Influenza virus (EIV), is endemic in many countries and outbreaks still have a severe impact on the equine industry globally. Conventional EI vaccines are widely used, but a need exists for a platform that facilitates prompt manufacturing of a highly immunogenic, antigenically matched, updated vaccine product. Here we developed a plant-produced bivalent EI virus-like particle (VLP) vaccine candidate which lacks the viral genome an...
Safety and immunogenicity of a sarcoid vaccine in horses.
Journal of equine veterinary science    February 10, 2025   Volume 146 105381 doi: 10.1016/j.jevs.2025.105381
Jacob O, Hause B, Peters-Smith K, Adam EN, Page AE, Floyd C, Tucker C, Eertink LG, Wang D, Li F.Equine sarcoids are the most identified skin tumors of horses, which are highly associated with bovine papillomavirus infection. Sarcoids can impair the use of the horse and are difficult to treat, resulting in significant economic losses and a welfare concern. There is no vaccine available to protect global equines from sarcoids. We aimed to determine the safety and protective antibody response in horses immunized with a recombinant baculovirus vector vaccine expressing the L1 protein of bovine papillomavirus type 1 (BPV1). A group of 10 clinically healthy, sarcoid-free horses were immunized ...
Multiple Gene Deletion Mutants of Equine Herpesvirus 1 Exhibit Strong Protective Efficacy Against Wild Virus Challenge in a Murine Model.
Vaccines    January 8, 2025   Volume 13, Issue 1 45 doi: 10.3390/vaccines13010045
Pradhan SS, Balena V, Bera BC, Anand T, Khetmalis R, Madhwal A, Kandasamy S, Pavulraj S, Bernela M, Mor P, Tripathi BN, Virmani N.Equine herpesvirus type 1 (EHV1) is a ubiquitous viral pathogen infecting the equine population worldwide. EHV1 infection causes respiratory illness, abortion, neonatal foal mortality, and myeloencephalopathy. The currently available modified live EHV1 vaccines have safety and efficacy limitations. The two mutant EHV1 viruses (vToH-DMV (∆IR6/gE) and vToH-QMV (∆IR6/UL43/gE/UL56)), generated by the deletion of genes responsible for virulence (gE and IR6) and immunosuppression (uL43 and uL56), have been previously characterized by our group and found to generate good immune responses. The pre...
A model-based approach to evaluate the effect of vaccination of the herd on transmission of equine herpesvirus 1 in naturally occurring outbreaks.
Preventive veterinary medicine    January 4, 2025   Volume 236 106418 doi: 10.1016/j.prevetmed.2025.106418
Houben RMAC, van Maanen C, Newton JR, van den Broek J, Sloet van Oldruitenborgh-Oosterbaan MM, Heesterbeek JAP.Equine herpesvirus 1 (EHV-1) infection is the cause of high impact disease syndromes, affecting the global horse industry. The effect of vaccination on transmission dynamics of EHV-1 in naturally occurring outbreaks is not quantified. Our aims were to estimate R for EHV-1 in equine populations from outbreak data, and evaluate the effect of vaccination status of the herd on R through a systematic review, model-based estimations and meta-analysis. A literature search for outbreak reports was carried out. Depending on available data, the early epidemic growth rate (GR) or final attack rate (AR) a...
A comparative study evaluating three line immunoassays available for serodiagnosis of equine Lyme borreliosis: Detection of Borrelia burgdorferi sensu lato-specific antibodies in serum samples of vaccinated and non-vaccinated horses.
PloS one    December 23, 2024   Volume 19, Issue 12 e0316170 doi: 10.1371/journal.pone.0316170
Broeckl CV, Hiereth S, Straubinger RK.Diagnosis of equine Lyme borreliosis (LB), an infection caused by members of the Borrelia burgdorferi sensu lato complex (Bbsl), is challenging due to the nonspecific clinical signs of the disease and due to the variety of non-standardized serological tests. Specific vaccine-induced antibodies against LB, providing an effective protection against the infection, complicate the issue further. The standard for the detection of specific antibodies against Bbsl is a two-tier test system based on an enzyme-linked immunosorbent assay (ELISA) or indirect fluorescent antibody test (IFA) for antibody sc...
West Nile Virus: An Update Focusing on Southern Europe.
Microorganisms    December 18, 2024   Volume 12, Issue 12 2623 doi: 10.3390/microorganisms12122623
Carrasco L, Utrilla MJ, Fuentes-Romero B, Fernandez-Novo A, Martin-Maldonado B.West Nile Virus (WNV) is a zoonotic, vector-borne pathogen affecting humans and animals, particularly in Europe. The virus is primarily transmitted through mosquitoes that infect birds, which serve as the main reservoirs. Humans and horses are incidental hosts. This review focuses on the epidemiology of WNV in southern Europe, particularly its increasing prevalence. Methods included an extensive literature review and analysis of recent outbreaks. WNV is largely asymptomatic in humans, but a small percentage can develop West Nile neuroinvasive disease (WNND), leading to severe neurological symp...
Immunization but not natural infection of horses results in antibody activity against the S protein of Streptococcus equi subsp equi.
American journal of veterinary research    December 16, 2024   1-11 doi: 10.2460/ajvr.24.08.0228
Cohen ND, Hughes EV, Bayne C, Morris ERA, Bray JM, Landrock KK, Gonzales DM, Baker RM, Klein RL, Liu W, Legere RM, Wehmeyer SG, Bordin AI....Evaluate the immunogenicity of a vaccine targeting the S protein (Ssee) of Streptococcus equi subsp equi and determine antibody activity against Ssee in horses with strangles. Methods: The study was designed as a prospective experiment using 20 university-owned Quarter Horses and a cross-sectional serosurvey of 78 privately owned horses with strangles. Horses were immunized IM with 0 (n = 4), 200 (n = 8), or 400 (n = 8) μg of recombinant Ssee at weeks 0, 4, and 12. Serum and nasal secretions were collected at weeks 0, 4, 6, 12, 16, and 28 and tested by ELISA for immunoglobulin (Ig)-G against ...
Immunization but not natural infection of horses results in antibody activity against the S protein of Streptococcus equi subsp equi.
American journal of veterinary research    December 16, 2024   1-11 doi: 10.2460/ajvr.24.08.0228
Cohen ND, Hughes EV, Bayne C, Morris ERA, Bray JM, Landrock KK, Gonzales DM, Baker RM, Klein RL, Liu W, Legere RM, Wehmeyer SG, Bordin AI....Evaluate the immunogenicity of a vaccine targeting the S protein (Ssee) of Streptococcus equi subsp equi and determine antibody activity against Ssee in horses with strangles. Methods: The study was designed as a prospective experiment using 20 university-owned Quarter Horses and a cross-sectional serosurvey of 78 privately owned horses with strangles. Horses were immunized IM with 0 (n = 4), 200 (n = 8), or 400 (n = 8) μg of recombinant Ssee at weeks 0, 4, and 12. Serum and nasal secretions were collected at weeks 0, 4, 6, 12, 16, and 28 and tested by ELISA for immunoglobulin (Ig)-G against ...
[Retrospective study of the effectiveness of human tyrosinase vaccination in eight horses].
Schweizer Archiv fur Tierheilkunde    December 3, 2024   Volume 166, Issue 12 648-656 doi: 10.17236/sat00340
Brunner S, Fürst AE, Jackson MA.Dermal melanoma is a common neoplastic disease in horses, which occurs particularly in gray horses. There are various local and systemic therapeutic approaches to treat this skin tumor. Vaccination with human tyrosinase, ONCEPT ® vaccine, is a newer type of systemic melanoma therapy. In this study, the effectiveness of this ONCEPT ® vaccine was retrospectively examined in eight treated horses. In half of the horses (4) a positive change in tumor growth in the sense of retardation, stagnation and, in one of these horses, even reduction in the size of the melanomas was observed. Of the rem...
Orthoflavivirus circulation in South-East Queensland, Australia, before and during the 2021-2022 incursion of Japanese encephalitis virus assessed through sero-epidemiological survey of a sentinel equine population.
One health (Amsterdam, Netherlands)    November 5, 2024   Volume 19 100930 doi: 10.1016/j.onehlt.2024.100930
Yuen NKY, Harrison JJ, Wang ASW, McMahon IE, Habarugira G, Coyle MP, Bielefeldt-Ohmann H.An incursion and outbreak of Japanese encephalitis virus (JEV) was reported in Australia in 2021 and 2022, respectively. There was speculation that JEV may have been circulating in Australia unknowingly prior to the detection. In this study, we determined sero-prevalence and transmission of West Nile virus (WNV), Murray Valley encephalitis virus (MVEV) and JEV, prior to and post JEV incursion in a sentinel equine population in south-east Queensland (SEQ), Australia, using blocking ELISAs (screening test) and virus neutralisation test (confirmatory). Serum samples collected between 2018 and 202...
Phenotypic Shift of an Inflammatory Eosinophil Subset into a Steady-State Resident Phenotype after 2 Years of Vaccination against IL-5 in Equine Insect Bite Hypersensitivity.
Veterinary sciences    October 5, 2024   Volume 11, Issue 10 476 doi: 10.3390/vetsci11100476
Schwarz E, Jebbawi F, Keller G, Rhiner T, Fricker A, Waldern N, Canonica F, Schoster A, Fettelschoss-Gabriel A.Eosinophils play a key role in allergic diseases such as insect bite hypersensitivity (IBH). Together with Th2 cells, they shape the course of inflammation in associated type I/IVb allergies. Therefore, a virus-like particle (VLP)-based vaccine targeting equine interleukin-5 (eIL-5), eIL-5-CuMV-TT, was developed to interfere with the IL-5 dependency of eosinophils by inducing the production of anti-self-IL-5 antibodies and alleviating clinical signs in IBH-affected horses. A previous study highlighted the presence of two eosinophil subsets, steady-state resident eosinophils (rEos) and inflamma...
Allergen immunotherapy using recombinant Culicoides allergens improves clinical signs of equine insect bite hypersensitivity.
Frontiers in allergy    September 30, 2024   Volume 5 1467245 doi: 10.3389/falgy.2024.1467245
Graner A, Mueller RS, Geisler J, Bogenstätter D, White SJ, Jonsdottir S, Marti E.Insect bite hypersensitivity (IBH) is an IgE-mediated allergic dermatitis of horses caused by bites of spp., sharing some common features with human atopic dermatitis. Allergen immunotherapy (AIT) using whole-body extracts has limited efficacy. This study aimed to evaluate AIT with a pool of major recombinant allergens in a prospective, double-blinded, placebo-controlled study. Unassigned: The IBH lesion score was assessed during a pre-treatment year and first treatment year (May-October) in 17 horses and in May and July of a second treatment year. Nine horses were immunized subcutaneously ...
Protective immune response against Rhodococcus equi: An innate immunity-focused review.
Equine veterinary journal    September 11, 2024   doi: 10.1111/evj.14214
da Silveira BP, Cohen ND, Lawhon SD, Watson RO, Bordin AI.Rhodococcus equi causes pyogranulomatous pneumonia in foals and immunocompromised people. Despite decades of research efforts, no vaccine is available against this common cause of disease and death in foals. The purpose of this narrative review is to summarise the current understanding of interactions between R. equi and the host innate immune system, to describe features of the immune response that are associated with resistance or susceptibility to R. equi infection, and help guide strategies for developing novel approaches for preventing R. equi infections. Virulence of R. equi in foals has...
Impact of equine herpesvirus-1 ORF15 (EUL45) on viral replication and neurovirulence.
Veterinary microbiology    August 22, 2024   Volume 298 110234 doi: 10.1016/j.vetmic.2024.110234
Kasem S, Yu MHH, Alkhalefa N, Ata EB, Nayel M, Abdo W, Abdel-Moneim AS, Fukushi H.Equine herpesvirus 1 (EHV-1) causes respiratory illness, fetal loss, perinatal mortality, and myeloencephalopathy. This study investigated ORF15's impact on virus infectivity and neurovirulence. The Ab4p neurovirulent strain of EHV1 was used as a backbone to create Ab4p attB, Ab4p∆ORF15, and Ab4p∆ORF15R chimeras via BAC DNA transfection into RK-13 cells. Viral growth kinetics, plaque size, transcription, and growth were assessed in MDBK cells, mouse neurons, and fetal equine brain cells. Neurovirulence was evaluated post-intranasal inoculation into male CBA/N1 SPF mice, measuring signs, vi...
The Silent Threat: Unraveling the Impact of Rabies in Herbivores in Brazil.
Animals : an open access journal from MDPI    August 8, 2024   Volume 14, Issue 16 doi: 10.3390/ani14162305
Ventura MCDS, Neves JMM, Pinheiro RDS, Santos MVC, de Lemos ERS, Horta MAP.Rabies, a zoonotic viral disease, poses a significant threat due to its adaptability to diverse environments. Herbivore rabies, predominantly affecting cattle, horses, and goats in Brazil, remains a concern, results in substantial losses in the livestock industry, and poses risks to public health. Rabies virus transmission, primarily through hematophagous bats in Latin America, underscores the need for effective strategies, and vaccination plays a crucial role in controlling herbivorous rabies, with systematic vaccination beingly the primary method. Efforts to control rabies in herbivores incl...
Polyclonal Peptide Antisera.
Methods in molecular biology (Clifton, N.J.)    July 13, 2024   Volume 2821 129-133 doi: 10.1007/978-1-0716-3914-6_10
Pihl TH, Engelhart KE, Houen G.Polyclonal antibodies are relatively easy to produce and may supplement monoclonal antibodies for some applications or even have some advantages.The choice of species for production of (peptide) antisera is based on practical considerations, including availability of immunogen (vaccine) and animals. Two major factors govern the production of antisera: the nature of adaptive immune responses, which take place over days/weeks and ethical guidelines for animal welfare.Here, simple procedures for immunization of mice, rabbits, sheep, goats, pigs, horses, and chickens are presented.
Antibody reactions of horses against various domains of the EHV-1 receptor-binding protein gD1.
PloS one    July 12, 2024   Volume 19, Issue 7 e0301987 doi: 10.1371/journal.pone.0301987
Schramm A, Ackermann M, Eichwald C, Aguilar C, Fraefel C, Lechmann J.Equid alphaherpesviruses 1 (EHV-1) and 4 (EHV-4) are closely related and both endemic in horses worldwide. Both viruses replicate in the upper respiratory tract, but EHV-1 may additionally lead to abortion and equine herpesvirus myeloencephalopathy (EHM). We focused on antibody responses in horses against the receptor-binding glycoprotein D of EHV-1 (gD1), which shares a 77% amino acid identity with its counterpart in EHV-4 (gD4). Both antigens give rise to cross-reacting antibodies, including neutralizing antibodies. However, immunity against EHV-4 is not considered protective against EHM. Wh...
Investigation of the Use of Environmental Samples for the Detection of EHV-1 in the Stalls of Subclinical Shedders.
Viruses    July 3, 2024   Volume 16, Issue 7 1070 doi: 10.3390/v16071070
Pusterla N, Lawton K, Barnum S.In populations of healthy show horses, the subclinical transmission and circulation of respiratory pathogens can lead to disease outbreaks. Due to recent outbreaks of equine herpesvirus-1 myeloencephalopathy (EHM) in the USA and Europe, many show organizers have instituted various biosecurity protocols such as individual horse testing, monitoring for early clinical disease and increasing hygiene and cleanliness protocols. The aim of this study was to determine the accuracy of detecting EHV-1 in the various environmental samples collected from the stalls of subclinical shedders. Four healthy ad...